View Older Stories View More Recent Stories

Oct 15, 2020 09:22AM Lilly (LLY) to Acquire Disarm Therapeutics for $135 Million Upfront
Oct 15, 2020 09:20AM Lilly Announces Agreement to Acquire Disarm Therapeutics
Oct 15, 2020 07:30AM Gemini Therapeutics and FS Development Corp. Announce Merger Agreement Creating Publicly Listed Precision Medicine Company Focused on Age-Related Macular Degeneration
Oct 1, 2020 07:00AM Korro Bio Appoints Omar Khwaja, M.D., Ph.D. to its Board of Directors
Sep 28, 2020 07:00AM Quench Bio is named one of Fierce Biotech's "Fierce 15" Biotech Companies of 2020
Sep 23, 2020 06:57PM Form 4 Dyne Therapeutics, Inc. For: Sep 21 Filed by: Atlas Venture Associates Opportunity I, L.P.
Sep 21, 2020 08:32AM KromaTiD Announces the Appointment of Vic Myer, PhD to its Board of Directors
Sep 17, 2020 04:51PM Form SC 13D/A Replimune Group, Inc. Filed by: Atlas Venture Fund X, L.P.
Sep 17, 2020 04:49PM Form 4 Replimune Group, Inc. For: Sep 15 Filed by: Atlas Venture Fund X, L.P.
Sep 16, 2020 08:40PM Form 3 Dyne Therapeutics, Inc. For: Sep 16 Filed by: Atlas Venture Fund XI, L.P.
Sep 15, 2020 01:10PM Compass Therapeutics, Inc. Provides Corporate Update
Sep 15, 2020 01:10PM Compass Therapeutics, Inc. Provides Corporate Update
Sep 10, 2020 07:00AM Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics
Aug 25, 2020 04:31PM Form 4 Kymera Therapeutics, For: Aug 25 Filed by: Atlas Venture Associates Opportunity I, LLC
Aug 20, 2020 08:40PM Form 3 Kymera Therapeutics, For: Aug 20 Filed by: Atlas Venture Fund X, L.P.
Aug 18, 2020 07:00AM Ikena Oncology Appoints Dr. Sergio Santillana, MD, MSc, MBA as Chief Medical Officer
Aug 12, 2020 07:00AM Ikena Oncology Announces Publication in Nature Communications of Preclinical Data Supporting the Therapeutic Potential of AHR Blockade
Aug 11, 2020 05:00PM Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
Aug 10, 2020 07:00AM Dyne Therapeutics Announces $115 Million Financing to Advance Pipeline of Modern Oligonucleotide Therapeutics for Serious Muscle Diseases
Aug 6, 2020 02:09PM Form 13F-NT ATLAS VENTURE FUND VI For: Jun 30
Aug 6, 2020 02:06PM Form 13F-NT Atlas Venture Associates For: Jun 30
Aug 6, 2020 02:03PM Form 13F-NT Atlas Venture Associates For: Jun 30
Aug 6, 2020 02:01PM Form 13F-HR Atlas Venture Associates For: Jun 30
Aug 6, 2020 01:59PM Form 13F-HR Atlas Venture Advisors, For: Jun 30
Aug 6, 2020 09:40AM Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy
Aug 4, 2020 04:05PM Cadent Therapeutics to Present at the William Blair Biotech Focus Conference
Aug 4, 2020 08:08AM Triplet Therapeutics To Present at Upcoming Events
Aug 3, 2020 07:00AM Dyne Therapeutics Appoints Susanna High as Chief Operating Officer
Jul 23, 2020 06:00AM Triplet Therapeutics Appoints Alan Buckler, Ph.D., as Chief Scientific Officer
Jul 22, 2020 12:46PM LeadingBiotech's Boston CEO&BD Conference Joins BioPharm America™ for a Must-Attend September Event
Jul 21, 2020 08:00AM Triplet Therapeutics Selects Clinical Candidate for Novel Treatment of Repeat Expansion Disorders
Jul 20, 2020 08:00AM Dyne Therapeutics Announces Appointment of Leading DMD Expert Francesco Muntoni to Scientific Advisory Board
Jul 14, 2020 04:35PM Form SC 13D Magenta Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Jul 13, 2020 07:06PM Form 3 Magenta Therapeutics, For: Jun 29 Filed by: Atlas Venture Associates Opportunity I, L.P.
Jul 7, 2020 06:55PM Form 4 Replimune Group, Inc. For: Jul 02 Filed by: Atlas Venture Fund X, L.P.
Jul 7, 2020 05:12PM Form SC 13D/A Replimune Group, Inc. Filed by: Atlas Venture Fund X, L.P.
Jul 6, 2020 10:17AM Unum Therapeutics Inc. (UMRX) Announces Acquisition of Kiq LLC
Jul 6, 2020 10:16AM Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
Jun 29, 2020 07:00AM Cadent Therapeutics to Participate in Upcoming Investor Conferences
Jun 23, 2020 01:00PM Claranova: Group Management and Governance Strengthened to Accelerate a New Expansion Phase
Jun 22, 2020 09:00AM Ikena Oncology Presents New Preclinical Data Highlighting the Anti-Cancer Effects of TEAD Inhibition on the Hippo Signaling Pathway
Jun 19, 2020 05:04PM Form SC 13D/A Replimune Group, Inc. Filed by: Atlas Venture Fund X, L.P.
Jun 18, 2020 05:28PM Form 4 Generation Bio Co. For: Jun 16 Filed by: Atlas Venture Associates Opportunity I, L.P.
Jun 18, 2020 04:37PM Form 4 Replimune Group, Inc. For: Jun 16 Filed by: Atlas Venture Fund X, L.P.
Jun 17, 2020 08:00AM Harvard Business School Introduces 2020-2021 Blavatnik Fellows in Life Science Entrepreneurship
Jun 11, 2020 08:38PM Form 3 Generation Bio Co. For: Jun 11 Filed by: Atlas Venture Associates Opportunity I, LLC
Jun 11, 2020 08:00AM Dyne Therapeutics Appoints Daniel Wilson as Vice President, Head of Intellectual Property
Jun 11, 2020 06:30AM Praxis Precision Medicines Promotes Business Leader Stuart Chaffee to Chief Financial Officer
Jun 8, 2020 07:00AM Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
Jun 8, 2020 07:00AM Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
View More Recent Stories View Older Stories